Selected research
Market Analysis & Forecast
Global Loratadine API Market Analysis and Forecast 2026-2032
Market perspective
The global Loratadine API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Loratadine API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Loratadine API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Loratadine API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Loratadine API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Loratadine API include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Loratadine API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Loratadine API, also provides the sales of main regions and countries. Of the upcoming market potential for Loratadine API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Loratadine API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Loratadine API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Loratadine API sales, projected growth trends, production technology, application and end-user industry.
Loratadine API Segment by Company
Shenzhen Salubris Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Merck Group
Mylan
Shaanxi Hanjiang
Changzhou Yabang
Changzhou Fangyuan Pharmaceutical
Vasudha Pharma Chem
Ultratech India Limited
Morepen
Inke, S.A.
Hetero Drugs Ltd
Cadila Pharmaceuticals
Argon Drugs
Loratadine API Segment by Type
Pharmaceutical Standards Grade
EP Standards Grade
USP Standards Grade
Others
Loratadine API Segment by Application
Loratadine Syrup
Loratadine Tablet
Loratadine Capsules
Dry Suspension
Others
Loratadine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Loratadine API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Loratadine API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Standards Grade
- EP Standards Grade
- USP Standards Grade
- Others
Applications
- Loratadine Syrup
- Loratadine Tablet
- Loratadine Capsules
- Dry Suspension
- Others
Companies covered
- Shenzhen Salubris Pharmaceuticals
- Shenzhen Haibin Pharmaceutical
- Merck Group
- Mylan
- Shaanxi Hanjiang
- Changzhou Yabang
- Changzhou Fangyuan Pharmaceutical
- Vasudha Pharma Chem
- Ultratech India Limited
- Morepen
- Inke, S.A.
- Hetero Drugs Ltd
- Cadila Pharmaceuticals
- Argon Drugs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Loratadine API Market by Type
- 1.2.1 Global Loratadine API Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pharmaceutical Standards Grade
- 1.2.3 EP Standards Grade
- 1.2.4 USP Standards Grade
- 1.2.5 Others
- 1.3 Loratadine API Market by Application
- 1.3.1 Global Loratadine API Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Loratadine Syrup
- 1.3.3 Loratadine Tablet
- 1.3.4 Loratadine Capsules
- 1.3.5 Dry Suspension
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Loratadine API Market Dynamics
- 2.1 Loratadine API Industry Trends
- 2.2 Loratadine API Industry Drivers
- 2.3 Loratadine API Industry Opportunities and Challenges
- 2.4 Loratadine API Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Loratadine API Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Loratadine API Revenue by Region
- 3.2.1 Global Loratadine API Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Loratadine API Revenue by Region (2021-2026)
- 3.2.3 Global Loratadine API Revenue by Region (2027-2032)
- 3.2.4 Global Loratadine API Revenue Market Share by Region (2021-2032)
- 3.3 Global Loratadine API Sales Estimates and Forecasts 2021-2032
- 3.4 Global Loratadine API Sales by Region
- 3.4.1 Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Loratadine API Sales by Region (2021-2026)
- 3.4.3 Global Loratadine API Sales by Region (2027-2032)
- 3.4.4 Global Loratadine API Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Loratadine API Revenue by Manufacturers
- 4.1.1 Global Loratadine API Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Loratadine API Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Loratadine API Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Loratadine API Sales by Manufacturers
- 4.2.1 Global Loratadine API Sales by Manufacturers (2021-2026)
- 4.2.2 Global Loratadine API Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Loratadine API Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Loratadine API Sales Price by Manufacturers (2021-2026)
- 4.4 Global Loratadine API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Loratadine API Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Loratadine API Manufacturers, Product Type & Application
- 4.7 Global Loratadine API Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Loratadine API Market CR5 and HHI
- 4.8.2 2025 Loratadine API Tier 1, Tier 2, and Tier 3
5 Loratadine API Market by Type
- 5.1 Global Loratadine API Revenue by Type
- 5.1.1 Global Loratadine API Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Loratadine API Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Loratadine API Revenue Market Share by Type (2021-2032)
- 5.2 Global Loratadine API Sales by Type
- 5.2.1 Global Loratadine API Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Loratadine API Sales by Type (2021-2032) & (k tons)
- 5.2.3 Global Loratadine API Sales Market Share by Type (2021-2032)
- 5.3 Global Loratadine API Price by Type
6 Loratadine API Market by Application
- 6.1 Global Loratadine API Revenue by Application
- 6.1.1 Global Loratadine API Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Loratadine API Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Loratadine API Revenue Market Share by Application (2021-2032)
- 6.2 Global Loratadine API Sales by Application
- 6.2.1 Global Loratadine API Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Loratadine API Sales by Application (2021-2032) & (k tons)
- 6.2.3 Global Loratadine API Sales Market Share by Application (2021-2032)
- 6.3 Global Loratadine API Price by Application
7 Company Profiles
- 7.1 Shenzhen Salubris Pharmaceuticals
- 7.1.1 Shenzhen Salubris Pharmaceuticals Company Information
- 7.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 7.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
- 7.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 7.2 Shenzhen Haibin Pharmaceutical
- 7.2.1 Shenzhen Haibin Pharmaceutical Company Information
- 7.2.2 Shenzhen Haibin Pharmaceutical Business Overview
- 7.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
- 7.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
- 7.3 Merck Group
- 7.3.1 Merck Group Company Information
- 7.3.2 Merck Group Business Overview
- 7.3.3 Merck Group Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Merck Group Loratadine API Product Portfolio
- 7.3.5 Merck Group Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Company Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mylan Loratadine API Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 Shaanxi Hanjiang
- 7.5.1 Shaanxi Hanjiang Company Information
- 7.5.2 Shaanxi Hanjiang Business Overview
- 7.5.3 Shaanxi Hanjiang Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
- 7.5.5 Shaanxi Hanjiang Recent Developments
- 7.6 Changzhou Yabang
- 7.6.1 Changzhou Yabang Company Information
- 7.6.2 Changzhou Yabang Business Overview
- 7.6.3 Changzhou Yabang Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Changzhou Yabang Loratadine API Product Portfolio
- 7.6.5 Changzhou Yabang Recent Developments
- 7.7 Changzhou Fangyuan Pharmaceutical
- 7.7.1 Changzhou Fangyuan Pharmaceutical Company Information
- 7.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
- 7.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
- 7.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
- 7.8 Vasudha Pharma Chem
- 7.8.1 Vasudha Pharma Chem Company Information
- 7.8.2 Vasudha Pharma Chem Business Overview
- 7.8.3 Vasudha Pharma Chem Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
- 7.8.5 Vasudha Pharma Chem Recent Developments
- 7.9 Ultratech India Limited
- 7.9.1 Ultratech India Limited Company Information
- 7.9.2 Ultratech India Limited Business Overview
- 7.9.3 Ultratech India Limited Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Ultratech India Limited Loratadine API Product Portfolio
- 7.9.5 Ultratech India Limited Recent Developments
- 7.10 Morepen
- 7.10.1 Morepen Company Information
- 7.10.2 Morepen Business Overview
- 7.10.3 Morepen Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Morepen Loratadine API Product Portfolio
- 7.10.5 Morepen Recent Developments
- 7.11 Inke, S.A.
- 7.11.1 Inke, S.A. Company Information
- 7.11.2 Inke, S.A. Business Overview
- 7.11.3 Inke, S.A. Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Inke, S.A. Loratadine API Product Portfolio
- 7.11.5 Inke, S.A. Recent Developments
- 7.12 Hetero Drugs Ltd
- 7.12.1 Hetero Drugs Ltd Company Information
- 7.12.2 Hetero Drugs Ltd Business Overview
- 7.12.3 Hetero Drugs Ltd Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
- 7.12.5 Hetero Drugs Ltd Recent Developments
- 7.13 Cadila Pharmaceuticals
- 7.13.1 Cadila Pharmaceuticals Company Information
- 7.13.2 Cadila Pharmaceuticals Business Overview
- 7.13.3 Cadila Pharmaceuticals Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
- 7.13.5 Cadila Pharmaceuticals Recent Developments
- 7.14 Argon Drugs
- 7.14.1 Argon Drugs Company Information
- 7.14.2 Argon Drugs Business Overview
- 7.14.3 Argon Drugs Loratadine API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Argon Drugs Loratadine API Product Portfolio
- 7.14.5 Argon Drugs Recent Developments
8 North America
- 8.1 North America Loratadine API Market Size by Type
- 8.1.1 North America Loratadine API Revenue by Type (2021-2032)
- 8.1.2 North America Loratadine API Sales by Type (2021-2032)
- 8.1.3 North America Loratadine API Price by Type (2021-2032)
- 8.2 North America Loratadine API Market Size by Application
- 8.2.1 North America Loratadine API Revenue by Application (2021-2032)
- 8.2.2 North America Loratadine API Sales by Application (2021-2032)
- 8.2.3 North America Loratadine API Price by Application (2021-2032)
- 8.3 North America Loratadine API Market Size by Country
- 8.3.1 North America Loratadine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Loratadine API Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Loratadine API Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Loratadine API Market Size by Type
- 9.1.1 Europe Loratadine API Revenue by Type (2021-2032)
- 9.1.2 Europe Loratadine API Sales by Type (2021-2032)
- 9.1.3 Europe Loratadine API Price by Type (2021-2032)
- 9.2 Europe Loratadine API Market Size by Application
- 9.2.1 Europe Loratadine API Revenue by Application (2021-2032)
- 9.2.2 Europe Loratadine API Sales by Application (2021-2032)
- 9.2.3 Europe Loratadine API Price by Application (2021-2032)
- 9.3 Europe Loratadine API Market Size by Country
- 9.3.1 Europe Loratadine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Loratadine API Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Loratadine API Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Loratadine API Market Size by Type
- 10.1.1 China Loratadine API Revenue by Type (2021-2032)
- 10.1.2 China Loratadine API Sales by Type (2021-2032)
- 10.1.3 China Loratadine API Price by Type (2021-2032)
- 10.2 China Loratadine API Market Size by Application
- 10.2.1 China Loratadine API Revenue by Application (2021-2032)
- 10.2.2 China Loratadine API Sales by Application (2021-2032)
- 10.2.3 China Loratadine API Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Loratadine API Market Size by Type
- 11.1.1 Asia Loratadine API Revenue by Type (2021-2032)
- 11.1.2 Asia Loratadine API Sales by Type (2021-2032)
- 11.1.3 Asia Loratadine API Price by Type (2021-2032)
- 11.2 Asia Loratadine API Market Size by Application
- 11.2.1 Asia Loratadine API Revenue by Application (2021-2032)
- 11.2.2 Asia Loratadine API Sales by Application (2021-2032)
- 11.2.3 Asia Loratadine API Price by Application (2021-2032)
- 11.3 Asia Loratadine API Market Size by Country
- 11.3.1 Asia Loratadine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Loratadine API Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Loratadine API Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Loratadine API Market Size by Type
- 12.1.1 SAMEA Loratadine API Revenue by Type (2021-2032)
- 12.1.2 SAMEA Loratadine API Sales by Type (2021-2032)
- 12.1.3 SAMEA Loratadine API Price by Type (2021-2032)
- 12.2 SAMEA Loratadine API Market Size by Application
- 12.2.1 SAMEA Loratadine API Revenue by Application (2021-2032)
- 12.2.2 SAMEA Loratadine API Sales by Application (2021-2032)
- 12.2.3 SAMEA Loratadine API Price by Application (2021-2032)
- 12.3 SAMEA Loratadine API Market Size by Country
- 12.3.1 SAMEA Loratadine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Loratadine API Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Loratadine API Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Loratadine API Value Chain Analysis
- 13.1.1 Loratadine API Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Loratadine API Production Mode & Process
- 13.2 Loratadine API Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Loratadine API Distributors
- 13.2.3 Loratadine API Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst